Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14296875 | 1.00 | MGAM (0.31) | MGAMCA1CA2GAASI | |
| SCHEMBL14477541 | 1.00 | MGAM (0.31) | MGAMCA1CA2GAASI | |
| SCHEMBL29703278 | 0.82 | MGAM (0.30) | MGAMCA1CA2GAASI | |
| SCHEMBL14296872 | 0.82 | MGAM (0.33) | MGAMCA1CA2GAASI | |
| SCHEMBL21683414 | 0.82 | MGAM (0.33) | MGAMCA1CA2GAASI | |
| SCHEMBL23288114 | 0.82 | MGAM (0.30) | MGAMCA1CA2GAASI | |
| SCHEMBL24509722 | 0.82 | MGAM (0.30) | MGAMCA1CA2GAASI | |
| SCHEMBL21685923 | 0.82 | MGAM (0.33) | MGAMCA1CA2GAASI | |
| SCHEMBL14478148 | 0.76 | SMN1; SMN2 (0.40) | — | |
| SCHEMBL12629943 | 0.76 | SMN1; SMN2 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8329925-B2 | Process for preparing substituted 1-O-acyl-2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranoses | LIBRAMEDICINA, INC. (JP) | 2012-12-11 | — | — | US | disclosed |
| US-20110152542-A1 | PROCESS FOR PREPARING SUBSTITUTED 1-O-ACYL-2-DEOXY-2-FLUORO-4-THIO-BETA-D-ARABINOFURANOSES | LIBRAMEDICINA, INC. (JP) | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152542-A1 | PROCESS FOR PREPARING SUBSTITUTED 1-O-ACYL-2-DEOXY-2-FLUORO-4-THIO-BETA-D-ARABINOFURANOSES | PFAS, FUCA2, UGT1A6 | MGAM 996/4885CA1 1785/4885CA2 4003/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.